[REGN] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
04-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -56.33%
YoY- -12.71%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 3,414,400 2,936,200 2,857,200 2,965,100 4,951,700 3,452,800 5,138,500 -23.79%
PBT 1,324,700 1,509,800 963,200 1,061,100 2,503,400 1,816,600 3,752,800 -49.95%
Tax 127,600 194,100 111,100 87,600 274,400 184,400 653,900 -66.25%
NP 1,197,100 1,315,700 852,100 973,500 2,229,000 1,632,200 3,098,900 -46.86%
Tax Rate -9.63% -12.86% -11.53% -8.26% -10.96% -10.15% -17.42% -
Total Cost 2,217,300 1,620,500 2,005,100 1,991,600 2,722,700 1,820,600 2,039,600 5.71%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 35.06 44.81 29.82 32.83 45.01 47.27 60.31 -30.27%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS 11.19 11.66 7.47 8.61 20.99 15.37 29.51 -47.51%
EPS Diluted 10.50 11.66 7.47 8.61 19.69 14.33 27.97 -47.86%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.